Valuation : Sartorius Stedim Biotech

Market Cap 19.14B 22.21B 17.94B 16.38B 30.86B 2,123B 30.96B 213B 83.06B 1,072B 83.39B 81.57B 3,553B P/E 2026 *
50.4x
P/E 2027 * 39.1x
Enterprise Value 21.15B 24.54B 19.83B 18.1B 34.1B 2,346B 34.21B 235B 91.78B 1,184B 92.14B 90.14B 3,926B EV / Sales 2026 *
6.76x
EV / Sales 2027 * 6.03x
Free-Float
28.47%
Yield 2026 *
0.42%
Yield 2027 * 0.51%
1 day+0.51%
1 week+1.38%
Current month+18.60%
1 month+21.51%
3 months+15.48%
6 months+7.97%
Current year-5.86%
1 week 190.4
Extreme 190.4
199.5
1 month 166
Extreme 166
199.5
Current year 150
Extreme 150
224
1 year 150
Extreme 150
224
3 years 139.1
Extreme 139.1
281
5 years 139.1
Extreme 139.1
551
10 years 50.13
Extreme 50.13
551
Manager TitleAgeSince
Chief Executive Officer 51 2023-03-27
Chief Tech/Sci/R&D Officer 61 2011-09-07
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 65 2015-04-06
Director/Board Member 69 2015-04-06
Director/Board Member 69 2017-09-13
Date Insider Type Main position Quantity % Market Cap.
12/17/25 SellCompany 750,000 0.7706%
2/16/24 Buy

Chief Executive Officer

1,716,739 1.8624%
3/2/22 SellCompany 200,442 0.2174%
Change 5-day change 1-year change 3-year change Capi.($)
+0.51%+1.38%+13.30%-20.44% 22.3B
+0.79%-3.58%-14.39%+9.42% 193B
+1.40%-2.27%-0.79%+12.09% 115B
+0.25%+1.25%+11.09%+78.52% 61.3B
-0.25%-3.31%+27.04%+55.45% 51.37B
+0.74%-1.29%-0.90%-32.69% 51.24B
+1.71%-1.65%+20.96%-8.53% 33.69B
+1.82%+2.98% - - 30.4B
-2.49%-4.42%+37.49%-16.34% 24.36B
-0.82%-1.46%-5.14%+22.13% 23.7B
Average +0.43%-0.07%+9.85%+11.07% 60.66B
Weighted average by Cap. +0.84%-0.98%+1.64%+14.89%

Financials

2026 *2027 *
Net sales 3.13B 3.63B 2.93B 2.68B 5.04B 347B 5.06B 34.77B 13.57B 175B 13.62B 13.32B 580B 3.47B 4.02B 3.25B 2.97B 5.59B 385B 5.61B 38.58B 15.05B 194B 15.11B 14.78B 644B
Net income 379M 440M 355M 324M 611M 42.04B 613M 4.22B 1.65B 21.22B 1.65B 1.62B 70.37B 481M 558M 451M 412M 775M 53.34B 778M 5.35B 2.09B 26.93B 2.1B 2.05B 89.29B
Net Debt 2.01B 2.33B 1.88B 1.72B 3.24B 223B 3.25B 22.36B 8.72B 113B 8.76B 8.57B 373B 1.76B 2.04B 1.65B 1.51B 2.84B 195B 2.85B 19.59B 7.64B 98.61B 7.67B 7.51B 327B
Logo Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key production sites are located in Germany, France and Puerto Rico.
Employees
10,477
Date Price Change Volume
26-08-28 197.70 +0.51% 56,919
26-08-27 €196.70 +2.45% 65,436
26-08-26 €192.00 -1.18% 49,412
26-08-25 €194.30 +1.62% 65,033
26-08-24 €191.20 -1.19% 43,628
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
197.70EUR
Average target price
232.64EUR
Spread / Average Target
+17.67%

Quarterly revenue - Rate of surprise